logo

Rigel Pharmaceuticals Inc. (RIGL)



Trade RIGL now with
  Date
  Headline
9/1/2021 7:36:50 AM Rigel Pharma : Phase 2 Trial Data Show Fostamatinib Improves Clinical Outcomes In Hospitalized COVID-19 Patients
8/3/2021 4:06:30 PM Rigel Pharma Q2 Loss/share $0.08 Vs. Loss $0.10 Year Ago
7/14/2021 7:31:53 AM Rigel Pharma Presents New TAVALISSE Data Analyses At ISTH 2021 Congress
5/14/2021 7:31:06 AM Rigel Pharmaceuticals Appoints Alison Hannah To Its Board
5/5/2021 4:06:14 PM Rigel Reports Q1 EPS Of $0.22 Vs. $0.13 Last Year
4/13/2021 7:02:23 AM Rigel Reports Positive Topline Results From Phase 2 Clinical Trial To Evaluate Safety Of Fostamatinib
4/7/2021 7:31:13 AM Rigel Announces Closing Of License Agreement With Lilly
3/11/2021 7:36:55 AM Rigel Completes Patient Enrollment For NIH/NHLBI-Sponsored Phase 2 Trial Of Fostamatinib In COVID-19 Patients
3/2/2021 4:02:42 PM Rigel Pharmaceuticals Q4 Loss/share $0.11 Vs. Loss $0.10 Year Ago